Literature DB >> 31656122

Neonatal Risk in Children of Women With Congenital Heart Disease: A Cohort Study With Focus on Socioeconomic Status.

Stine Kloster1, Janne S Tolstrup1, Morten Smærup Olsen2, Søren Paaske Johnsen3, Lars Søndergaard4,5, Dorte Guldbrand Nielsen6,7, Annette Kjær Ersbøll1.   

Abstract

Background We hypothesized that women with congenital heart disease (CHD) are at increased risk of giving birth preterm, including very and moderately preterm and giving birth to infants small for gestational age (SGA). We aimed to investigate this in a nation-wide study with focus on the potential modifying effect of socioeconomic status. Methods and Results We performed a cohort study using Danish nation-wide registers between 1997 and 2014. The exposure, maternal CHD, was subdivided into simple, moderate and complex based on severity of defects. Outcomes were preterm birth and SGA. Cox regression was used to estimate hazard ratios (HR). A total of 933 149 births including 3745 births among women with CHD were studied. The risk of giving birth preterm and SGA were higher among women with CHD as compared with women without CHD; for example, adjusted hazard ratios of preterm birth according to severity: simple 1.33 (95% CI, 1.11-1.59), moderate 1.45 (95% CI, 1.14-1.83) and complex 3.26 (95% CI, 2.41-4.40). Same pattern was seen for very and moderately preterm births and SGA. Education was a strong predictor of both preterm birth and SGA but did not modify the association between maternal congenital heart disease and preterm birth (P=0.38) or SGA (P=0.99). Conclusions Women with CHD were at increased risk of preterm birth both, moderately and very preterm, as well as giving birth to infants SGA. Education was a strong predictor of both preterm birth and SGA but the association between CHD and risk of preterm birth and SGA was independent of educational level.

Entities:  

Keywords:  congenital heart disease; pregnancy; preterm birth; small for gestational age; socioeconomic position

Mesh:

Year:  2019        PMID: 31656122      PMCID: PMC6898817          DOI: 10.1161/JAHA.119.013491

Source DB:  PubMed          Journal:  J Am Heart Assoc        ISSN: 2047-9980            Impact factor:   5.501


Clinical Perspective

What Is New?

We showed that the risk of preterm birth, both moderately and very preterm, was higher among women with congenital heart disease in an unselected population. Socioeconomic status was a strong predictor of preterm birth and small for gestational age also among women with congenital heart disease, however, the association between congenital heart disease and risk of preterm birth and small for gestational age apparently seemed to be independent of socioeconomic status in a population with free and equal access to health care.

What Are the Clinical Implications?

In particular, the increased risk of very preterm birth may potentially be used during counselling regarding risk in pregnancy among women with a congenital heart disease. The difference in risk between different socioeconomic groups for both preterm birth and small for gestational age in a country with free and equal access to health care need awareness and mechanisms behind this inequality among women with congenital heart disease need to be addressed.

Introduction

Because of advances in diagnosis and treatment, more women with congenital heart disease (CHD) are reaching childbearing age compared with earlier.1, 2 Some CHDs increase risk of obstetric and cardiac complications during pregnancy and childbirth.3, 4, 5, 6, 7, 8, 9, 10, 11 Likewise, studies indicate an increased risk of adverse neonatal outcomes such as premature birth and small for gestational age (SGA),3, 9, 12, 13, 14, 15 which are predictors of neonatal morbidity and mortality,16, 17 and morbidity in adult life.18 The adverse effect of being born preterm is associated with the degree of prematurity. However, the association between maternal CHD and preterm birth primarily focus on preterm birth, and only a few studies examine degree of prematurity.19, 20 These studies are limited by the small sample sizes and selected study populations. Hence, evidence of the risk of very premature birth in the general population of women with CHD is still lacking. Preterm birth and giving birth to an SGA infant in general occur more commonly among disadvantaged socioeconomic groups,21 thereby contributing to inequalities in health. However, whether this inequality also exists among women with CHD is unknown. A study showed no association between countries with different Human Development Index and the rate of SGA among women with CHD; however, individual socioeconomic status was not accounted for.22 We hypothesized that women with CHD, who have entered 22 completed weeks of pregnancy (ie, gestational age is 154 days), are at increased risk of giving birth preterm, including very (22–31 completed weeks) and moderately (32–36 completed weeks) preterm and giving birth to SGA infants. We aimed to investigate this in a nation‐wide study with particular focus on the potential modifying effect of socioeconomic status at an individual level.

Methods

Study Design

In Denmark, all citizens have free access to health care and are assigned a unique identification number, which enables individual‐level linkage across national registers.23 The study was a national cohort study with prospectively collected data from the Danish Medical Birth Register24, 25 and the Danish National Patient Register.26 Data will not be made available to other researchers for the purpose of reproducing the results because this would be a violation of the Danish General Data Protection Regulation and data Privacy Regulation by Statistic Denmark.

Study Population

All births registered in the Danish Medical Birth Register between 1997 and 2014 constituted the study population. All singleton births among women born in Denmark were included (n=952 882). The register holds information on all live and stillbirths, including information of both mother and child related to the pregnancy and delivery.24, 25 Women were included in the cohort at day 154 of gestation (22 completed weeks) and followed until birth.

Maternal Congenital Heart Disease

Information about maternal CHD was obtained from the Danish National Patient Register, which is a population‐based administrative register holding information on all hospital admissions since 1977.26 All women with a diagnosis of CHD (International Classification of Diseases, Tenth Revision [ICD‐10]; Q20–Q26, International Classification of Diseases, Eighth Revision [ICD‐8]; 746–747) between 1977 and 2016 were included except ICD‐10 Q26.5 to Q26.6 and ICD‐8 746.7 and 747.5 to 747.9, which are not specific for CHD. To increase the positive predictive value of the diagnosis of CHD, we excluded individuals with, for example, unspecific diagnoses using an algorithm previously described.27 For example, diagnosis of ASD was excluded if given at ages <2 months without an associated operation code; diagnosis of congenital stenosis of aortic valve was excluded if given at ages >40 years, etc (see appendix in Olsen et al for more details27). Based on guidelines from the European Society of Cardiology, CHD was categorized into no, simple, moderate, and complex.28 Women with >1 diagnosis were categorized according to the more‐severe diagnosis. We included women diagnosed before, during, and after pregnancy under the hypothesis that underlying CHD affected the pregnancy and its outcome irrespective of whether the disease was diagnosed at the time of delivery.

Outcomes

Information on preterm birth and SGA was obtained from the Danish Medical Birth Register.24, 25 During the study period, gestational age was primarily determined based on ultrasonography. Preterm birth was defined as birth between 22 and 36 weeks of completed gestation (154–258 days). Preterm birth was further categorized into very preterm (22–31 completed weeks) and moderately preterm (32–36 completed weeks).29, 30 Births with implausible birthweights according to gestational age were excluded.31 SGA was defined as birthweight falling below the 10th percentile of birthweight according to standard references32 and calculated for males and females, separately.

Covariates

Ethnicity, maternal age, parity, educational level, and calendar year were identified as confounders a priori using Directed Acyclic Graphs (available from the authors).33 Information about ethnicity was obtained from the Danish Civil Registration System and grouped into Europeans/North Americans, Asians, and Africans/others. This was done because CHD is more prevalent among Asians and Europeans34 and preterm birth is more prevalent among Africans.35 Maternal age and calendar year were assessed at inclusion. Age was categorized into: <20, 20 to 24, 25 to 29, 30 to 34, and ≥35 years. Year of inclusion was grouped into 5‐year bands, except the last interval which contained 4 years. Information about parity was obtained from the Danish Medical Birth Register and grouped into nulli‐, primi‐, and multiparous. Parity was corrected based on the available information in the Danish Medical Birth Register (Data S1). Socioeconomic status was assessed by educational level, which has shown to be a strong socioeconomic predictor of the risk of both preterm birth and SGA in Denmark.29 Information about the highest level of completed education October 1 the year preceding each birth was obtained from the Danish Education Register.36 Education was classified according to the International Standard Classification of Education System (ISCED 2011)37 and categorized into 3 groups: low education (preprimary, primary, and lower secondary; ISCED level 1–2); medium (upper secondary and postsecondary; ISCED level 3–4); and high (tertiary education ISCED level 5–8). For descriptive purposes information on smoking, prepregnancy body mass index, number of hospital contacts 1 year before start of the index pregnancy, stillbirths, and induction was included.

Statistical Analysis

For the descriptive analyses, median and interquartile range was used for continuous variables, and counts with proportions was used for categorical variables. A Cox proportional hazard model was used to investigate the association between maternal CHD and preterm birth and SGA. Gestational age in days was used as the underlying time scale. Women entered the cohort at day 154 of gestation. For preterm birth, the follow‐up time was terminated at birth or after 258 days of gestation, whichever came first. Pregnancies ending with stillbirth were censored at the time of stillbirth or after 258 days. When analyzing the risk of very preterm birth, the follow‐up time was terminated at birth or after 223 days (cut point for very preterm birth, <32 completed weeks), and all ongoing pregnancies were censored. When analyzing the risk of moderately preterm birth, all pregnancies not ending in a very preterm birth were included and follow‐up time was terminated at birth or after 258 days. When analyzing the association with SGA, the pregnancies were followed until birth. Adjustment was made for maternal age, calendar year, ethnicity, parity, and educational level. Some women contributed with >1 birth to the cohort. To account for the clustered structure of the data, a cluster‐robust standard error estimator was used. Results were presented as hazard ratios (HRs) with 95% CIs. The overall effect of CHD and educational level was derived using Wald's test. The possible effect modification of educational level on the association between CHD and the outcomes was tested on a multiplicative scale by including the main effects and the interaction term in the fully adjusted model. Wald's test was used to test whether the interaction was significant. The joint effect was examined by combining CHD and educational level into a single variable with 12 categories with a common reference group (women with high education without CHD). Differences in HRs between complex CHD and no CHD were compared at the different educational levels using Wald's test: low versus medium, low versus high, and medium versus high. Likewise, this was done for simple and moderate CHD. The proportional hazard assumption was evaluated visually using log‐log plots. Births with missing information on gestational age and birthweight were excluded.

Sensitivity Analysis

The assumption of proportional hazards was violated for the age category <20 years for preterm birth. To examine whether this affected the estimates of the main exposure (CHD), all analyses were conducted in strata of age and by including an interaction term between age and gestational age. To further examine the potential influence of nonproportional hazards, all analyses were also conducted using a Poisson regression of incidence rates. Several sensitivity analyses were conducted. First, the risk of preterm birth was modeled with stillbirth as a competing risk. Second, analyses of preterm birth and SGA were restricted to women diagnosed with CHD before delivery to examine the effect of knowing the disease beforehand. Third, the analysis was restricted to nulliparous women in order to eliminate the effect of any similar previous pregnancy outcome (eg, preterm birth). Fourth, induced births were modeled as a competing risk to spontaneous preterm births. Last, an analysis was conducted where SGA was defined as birthweight below 2 SDs of the mean birthweight according to standard references32 and calculated for males and females, separately. This was done because both <10th percentile and 2 SDs below the mean are used in the literature. The definition with 2 SDs only captures the most extreme SGA infants. Data management done in order to derive the CHD cohort was done using SAS software (version 9.4; SAS Institute Inc, Cary, NC. All analyses were performed using Stata/IC software (version 15.0; StataCorp LP, College Station, TX).

Ethical Considerations

The study was approved by the Danish Data Protection Agency (2015‐57‐0008, no. 16/48885). In Denmark, written informed consent or ethical approval is not required for register‐based studies. All data were provided by Statistics Denmark, and because of their data privacy regulation, data with <5 individuals per cell were not reported.

Results

Participants

We identified 952 882 singleton births in the study period. Of these, 218 births were excluded because pregnancy ended before 22 (n=159) or after 44 (n=59) weeks of completed gestation, 577 births because of implausible birthweights, and 18 938 (≈2%) births because of missing information on gestational age resulting in a study population of 933 149 births among 548 714 women (Figure 1). Birthweight was missing for another 7024 (0.75%) births, and the analysis sample for SGA therefore consisted of 926 125 births among 546 903 women. A total of 3745 births were among 2212 women with CHD.
Figure 1

Flow diagram of data from the Danish Medical Birth Register.

Flow diagram of data from the Danish Medical Birth Register.

Maternal and Birth Characteristics

The most common CHDs were the simple defects, atrial septal defect and ventricular septal defect. Within complex CHDs, transposition of the great arteries constituted the majority of diagnosis. The distribution of each CHD, stratified by complexity, is reported in Table S1. Compared with women without CHD, women with CHD were slightly younger, less educated, and more were nulliparous (Table). Furthermore, there were a larger proportion of stillbirths and inductions among women with CHD, and they had, on average, more hospital contacts the year before pregnancy as compared with women without CHD.
Table 1

Baseline Characteristics by Congenital Disease Status in 548 714 Women and 933 149 Births

Maternal Congenital Heart Disease
No (n=929 462)Simple (n=2224)Moderate (n=1082)Complex (n=381)
N(%)N(%)N(%)N(%)
929 46222241082381
Age, y
Median (IQR)30.1 (26.9–33.4)29.3 (25.6–32.6)29.5 (26.4–32.8)29.0 (25.7–32.4)
<201.83.82.92.4
20 to 2412.318.114.019.4
25 to 2935.234.238.334.9
30 to 3434.931.631.932.8
≥3515.812.312.910.5
Ethnicity929 45522241082381
Europeans/North Americans99.498.599.798.2
Asians0.5<30a NAb <5a NAb <5a NAb
Africans/others0.1<30a NAb <5a NAb <5a NAb
Parity917 49921981069380
Nulliparous43.848.448.445.3
Primiparous38.736.337.035.0
Multiparous17.515.314.619.7
Education917 42722191067372
Low19.127.122.627.2
Medium43.740.341.446.8
High37.232.636.026.1
Smoking845 0782068972341
Yes17.619.715.417.3
Prepregnancy BMI531 0491462682246
Underweight (<18.5)4.14.95.75.7
Normal (18.5–<25)62.462.362.265.8
Overweight (≥25)33.532.832.128.5
No. of hospital contacts 1 year before start of pregnancyc 929 46222241082381
Median (IQR)0 (0–1)0 (0–1)0 (0–1)0 (0–2)
Mean±SD0.63±1.350.91±1.650.88±1.631.05±1.75
Stillbirth29420.3160.790.861.6
Induction overall136 84514.740118.019618.17218.9
Induction among preterm births553312.01510.01316.7<5a NAb

N indicates number of births; BMI indicates body mass index; IQR, interquartile range; NA, not applicable.

Exact n is not given because of data privacy policy. The exact number is known by the researchers and used in calculations.

Not applicable because of low n.

Number of contacts the year before the start of the index pregnancy. Contacts with primary reason of congenital heart disease or pregnancy were excluded.

Baseline Characteristics by Congenital Disease Status in 548 714 Women and 933 149 Births N indicates number of births; BMI indicates body mass index; IQR, interquartile range; NA, not applicable. Exact n is not given because of data privacy policy. The exact number is known by the researchers and used in calculations. Not applicable because of low n. Number of contacts the year before the start of the index pregnancy. Contacts with primary reason of congenital heart disease or pregnancy were excluded. The overall proportion of preterm birth was 5.0% (n=46 601) and SGA 10.5% (n=96 802). The median gestational age was 280 days (interquartile range, 273–287). Median follow‐up time (ie, time from 154 days of gestation to censoring or birth) was 105 days (range, 1–105) in the analysis of preterm births and 127 days (range, 1–161) in the analysis of SGA.

Main Results

Women with CHD had a higher risk of any preterm birth as compared with women without CHD (Figure 2A). The risk of preterm birth increased with increasing severity of the maternal CHD, with an HR of 1.33 (95% CI, 1.11–1.59) for simple, 1.45 (95% CI,1.14–1.83) for moderate, and 3.26 (95% CI, 2.41–4.40) for complex defects. The same pattern was found when analyzing subgroups of preterm birth with even higher HR of very preterm birth with an HR at 1.62 (95% CI, 1.09–2.39) for simple, 1.37 (95% CI, 0.70–2.70) for moderate, and 5.02 (95% CI, 2.84–8.90) for complex defects. Adjustment for confounders did not affect the HRs substantially, for example, 3% for any preterm birth (crude estimates in Table S2).
Figure 2

A, Hazard ratios (HRs) of the association between severity of maternal congenital heart disease and preterm birth and small for gestational age. HRs are adjusted for maternal age and calendar year at inclusion, ethnicity, parity, and level of education. Women without congenital heart disease are used as a reference. *Not significantly different from simple congenital heart disease. B, HRs of the association between educational level and preterm birth and small for gestational age. HRs are adjusted for congenital heart disease, maternal age, and calendar year at inclusion, ethnicity, and parity. Women with a high level of education are used as a reference.

A, Hazard ratios (HRs) of the association between severity of maternal congenital heart disease and preterm birth and small for gestational age. HRs are adjusted for maternal age and calendar year at inclusion, ethnicity, parity, and level of education. Women without congenital heart disease are used as a reference. *Not significantly different from simple congenital heart disease. B, HRs of the association between educational level and preterm birth and small for gestational age. HRs are adjusted for congenital heart disease, maternal age, and calendar year at inclusion, ethnicity, and parity. Women with a high level of education are used as a reference. Likewise, the risk of giving birth to an infant born SGA was higher among women with CHD as compared with women without. As for preterm birth, the risk increased with increasing severity of the heart disease; adjusted HRs of simple 1.27 (95% CI, 1.11–1.45), moderate 1.56 (95% CI, 1.29–1.87), and complex 2.32 (95% CI, 1.69–3.18) defects. A lower educational level was strongly associated with higher risk of any preterm birth (Figure 2B). The adjusted HRs of low and medium education as compared with high education was 1.76 (95% CI, 1.71–1.82) and 1.25 (95% CI, 1.22–1.28), respectively. The association between maternal CHD and any preterm birth was independent of educational level (P value for interaction=0.38). HRs of preterm birth and SGA within strata of education are given in Figure 3.
Figure 3

To the left, hazard ratios (HRs) of preterm birth (upper) and small for gestational age (SGA; lower) for the joint effect of educational level and maternal congenital heart disease are given. To the right, HRs of preterm birth (upper) and SGA (lower) by maternal congenital heart disease within strata of educational level are given. *Adjusted for maternal age and calendar year at inclusion, ethnicity, and parity. †Differences in HR between women without congenital heart disease and women with a complex congenital heart disease were significantly higher for women with a low education as compared with women with a medium education (P=0.03). P value of interaction; preterm birth, P=0.38; SGA, P=0.99.

To the left, hazard ratios (HRs) of preterm birth (upper) and small for gestational age (SGA; lower) for the joint effect of educational level and maternal congenital heart disease are given. To the right, HRs of preterm birth (upper) and SGA (lower) by maternal congenital heart disease within strata of educational level are given. *Adjusted for maternal age and calendar year at inclusion, ethnicity, and parity. †Differences in HR between women without congenital heart disease and women with a complex congenital heart disease were significantly higher for women with a low education as compared with women with a medium education (P=0.03). P value of interaction; preterm birth, P=0.38; SGA, P=0.99. Differences in HR between each group of CHD and women without were similar between educational levels. The only exception was among women with a complex CHD, where differences in HR were significantly higher for women with a low education as compared with women with a medium education (Figure 3). Likewise, education was strongly associated with SGA (Figure 2B). The adjusted HRs of low and medium education as compared with high education was 1.96 (95% CI, 1.92–2.00) and 1.26 (95% CI, 1.24–1.28), respectively. As for preterm births, the association between CHD and SGA was independent of educational level (P value for interaction=0.99). Differences in HR among women with CHD and women without were similar at all educational levels.

Sensitivity Analyses

Cox regressions conducted in strata of age or by including an interaction term between age and gestational age showed that HRs for simple, moderate, and complex defects were essentially the same. Likewise, estimates of CHD were similar when analyses were run as Poisson regression of incidence rates. However, for very preterm birth, the analysis did not converge. Modelling stillbirth as a competing risk to preterm birth essentially gave the same estimates (Table S3). Restricting the analysis to women diagnosed with CHD before the index pregnancy showed the same pattern, but resulted in slightly higher adjusted HR, for example, simple 1.39 (95% CI, 1.14–1.69) and complex 3.40 (95% CI, 2.49–4.65) for preterm birth (Table S4). Restricting the analysis to nulliparous women resulted in the same pattern as for the full cohort (Table S5). However, the differences for simple and moderate were only borderline significant. Modeling induced births as a competing risk to spontaneous preterm birth, the pattern and size of estimates were almost similar (Table S6). When defining SGA as infants falling below 2 SDs of the mean birthweight, the same pattern was noted. However, the HR of SGA was higher for complex CHD when the definition of 2 SDs was used (Table S7).

Discussion

We found that women with CHD had a higher risk of preterm birth, both moderately and very preterm, and SGA. Furthermore, the risk of both outcomes increased with severity of the CHD. Socioeconomic status, as determined by maternal educational level, was a strong predictor of preterm birth and SGA. The association between CHD and risk of preterm birth and SGA apparently seems to be independent of educational level; however, this could be attributable to low power because of few events. Our results add to the literature showing that maternal CHD is associated with preterm birth and SGA.3, 9, 12, 13, 14, 15 Although some studies found no association between preterm birth or SGA and CHD,8, 38 this may be attributable to small sample sizes. By including the total population of pregnant women with and without CHD in Denmark during 18 years, we obtained a large sample size to estimate the association between CHD and preterm birth and SGA, thereby contributing with solid evidence from a nation‐wide register in a country with universal and free healthcare coverage. Our estimates are similar to the findings of Hayward et al, who report an odds ratio of 1.6 for noncomplex and 3.0 for complex CHD.13 The definition of severity differs because they categorized CHD into complex and noncomplex; however, the definition of complex CHD is similar with the primary exception of tetralogy of Fallot, which, in our study, is categorized as a moderate defect. Thompson et al5 evaluated women with CHD as 1 group and found an odds ratio of 1.66. This is a lower estimate compared with ours when considered that women with complex CHD are included in the estimate. In both studies, the researchers adjusted for comorbidities that might be mediators of the association between CHD and preterm birth. To our knowledge, the degree of prematurity has not previously been determined in the general population of women with CHD. Only a few small studies report event frequencies of degree of prematurity.19, 20 We report a higher risk of both very preterm and moderately preterm births among women with CHD. Births among women with CHD are more often induced20, 39 which is also the case in our study. However, among preterm births, there was no difference in frequency of induction among women with CHD and women without (data not shown). Furthermore, when induction was modeled as a competing risk to spontaneous preterm births, the results were similar as in the main analysis, indicating that the association is not attributable to difference in induction among women with and without CHD. Our results add to the evidence that maternal CHD predisposes to a lower fetal growth rate. As recently shown, women with CHD have smaller babies compared with healthy women.12 Similar findings have been reported by others.5, 8, 15, 19 However, the size of effect differs between studies and might partly be explained by differences in the definition of SGA. When SGA was defined as infants falling below 2 SDs of the mean birthweight, we found the same pattern. However, the HR of SGA was higher among women with a complex CHD. Given that defining SGA as falling below 2 SDs of the mean birthweight only captures the most extreme SGA infants, this might indicate that women with a complex CHD tend to give birth to smaller infants and this effect is then attenuated when the definition of SGA is broader. Regardless of the definition of SGA, the restriction in fetal growth among women with CHD could be attributable to a reduced cardiac output that causes a disturbed uteroplacental blood flow.40, 41

Influence of Socioeconomic Status

Little is known about if and how socioeconomic status affects birth outcome among women with CHD. Our results indicate that inequality in adverse birth outcomes does exist among women with CHD even in a country with free and equal access to health care. The educationally patterned risk of preterm birth and SGA is worrying because this might be the first sign of health inequality in health in later life.21 This might be even more pronounced among children of women with CHD given that more of these children will have CHD and other malformations themselves,15 which are also known to cluster in more socially disadvantaged groups,21 thereby placing children of women with CHD as a particularly vulnerable group with higher concentration of risk factors for inequality in health in later life. Children with CHD will furthermore tend to achieve a lower educational level,42 and thereby social inequality is passed across generations. Additionally, it has been well documented that the inequality in health does exist in the risk of disease, as shown in this study, but also in the consequence of disease.43

Research and Clinical Implications

We showed a 5‐fold increased risk of very preterm birth among women with a complex CHD. Therefore, the risk of preterm birth is not just a question of giving birth close to term. This is of clinical importance given that the adverse effects of being born preterm differ by degree of prematurity. This information might be used in future counseling regarding risk in pregnancy among women with CHD. Furthermore, children born to women with CHD will be at increased risk of being born SGA, making these children even more vulnerable. In Denmark, all citizens have free and equal access to health care; however, we found a socioeconomic patterned risk of preterm birth and SGA. The mechanism behind this association is complex and not completely understood,44 but might partly be explained by differences in health behavior and differences in the experience of social advantages or disadvantages across the life course.45 However, the mechanisms behind this might differ for women with and without CHD and need further investigation. Factors such as preeclampsia and gestational hypertension might be important to consider when predicting the risk of preterm birth and SGA among women with CHD. However, we consider these conditions as mediators on the causal path from maternal CHD to preterm birth or SGA. Therefore, these conditions were not included in the statistical analysis.46 Higher prevalence of preeclampsia/eclampsia or other gestational hypertensive disorders have been reported among women with heart disease.9, 13 To investigate the mediating factors between CHD and adverse perinatal outcomes was beyond the scope of this article. However, in order to reduce adverse neonatal outcomes among women with CHD, future studies should focus on the mediating factors between CHD and adverse neonatal outcomes. Neonatal complications tend to follow a pattern similar to maternal and obstetric outcomes among women with heart disease in general,9 indicating that the association between CHD and these different outcomes might be mediated through shared factors.

Strengths and Limitations

Inclusion of all women diagnosed with a CHD in Denmark, as opposed to including from specialized clinics, limits the risk of selection bias. Additionally, this increases power to analyze subgroups of preterm births. Given that data are based on a nation‐wide sample, we were able to include women with simple CHD, who constitute the biggest part of women with CHD and, as shown in this study, also have a higher risk of preterm birth and SGA than women without CHD. Furthermore, this improves the ability to transfer the results to a real‐world setting. When analyses were restricted to nulliparous women findings were similar, which strengthen the main findings in the study, ruling out that risks are attributable to previous similar birth outcomes such as preterm birth. A further strength of our study is the validation of CHD diagnosis. As recently described, the use of diagnosis of CHD from administrative databases is associated with some inaccuracy.47 In general, diagnosis of CHD has a high positive predictive value in the Danish National Patient Register,48, 49 and to further increase the validity of the included diagnoses, we used an algorithm previously described27 to exclude invalid diagnosis of CHD or inaccurate coding in the Danish National Patient Register. The Danish universal healthcare system with free and equitable access to care regardless of economic resources offers unique possibilities for studying the socioeconomic gradient in risk of preterm birth and SGA among women with CHD. We were able to include information about socioeconomic status at an individual level, which, to our knowledge, has not previously been done among women with CHD. A drawback of the study is the inability to account for the variability in severity within both the CHD category, but also within a given diagnosis of CHD. In conclusion, our study showed that women with CHD were at increased risk of preterm birth, both moderately and very preterm, and giving birth to an SGA infant. The risk was higher in complex CHD. Education was a strong predictor of both preterm birth and SGA, with higher risk among lower‐educated women. However, the association between CHD and risk of preterm birth and SGA apparently seems to be independent of educational level in a country with universal healthcare coverage.

Sources of Funding

The study was funded by the Danish Heart Association. Funders had no influence on study design, analysis, manuscript preparation, or publications.

Disclosures

None. Data S1. Supplemental methods. Table S1. Distribution of Congenital Heart Disease Table S2. Crude Hazard Ratios of Preterm Birth and Small for Gestational Age Among Women With Congenital Heart Disease Table S3. Hazard Ratios of Preterm Among Women With Congenital Heart DiseaseStillbirth as Competing Risk Table S4. Hazard Ratio of Preterm Birth and Small for Gestational Age Among Women Diagnosed With Congenital Heart Disease Before Delivery Table S5. Hazard Ratio of Preterm Birth Restricted to Nulliparous Women Table S6. Hazard Ratio of Spontaneous Preterm Birth—Stillbirth and Induction as Competing Risk Table S7. Hazard Ratio of SGA (SGA Defined as Falling Below 2 SDs of the Mean Birth Weight Click here for additional data file.
  46 in total

Review 1.  Socioeconomic disparities in adverse birth outcomes: a systematic review.

Authors:  Philip Blumenshine; Susan Egerter; Colleen J Barclay; Catherine Cubbin; Paula A Braveman
Journal:  Am J Prev Med       Date:  2010-09       Impact factor: 5.043

2.  Effect of maternal heart disease on fetal growth.

Authors:  Emily Gelson; Ruth Curry; Michael A Gatzoulis; Lorna Swan; Martin Lupton; Philip Steer; Mark Johnson
Journal:  Obstet Gynecol       Date:  2011-04       Impact factor: 7.661

Review 3.  Risk assessment and management to prevent preterm birth.

Authors:  B Koullali; M A Oudijk; T A J Nijman; B W J Mol; E Pajkrt
Journal:  Semin Fetal Neonatal Med       Date:  2016-02-18       Impact factor: 3.926

4.  Prevalence and descriptive analysis of congenital heart disease in parturients: obstetric, neonatal, and anesthetic outcomes.

Authors:  Christine M Warrick; Jan E Hart; Anne M Lynch; Joy A Hawkins; Brenda A Bucklin
Journal:  J Clin Anesth       Date:  2015-07-03       Impact factor: 9.452

5.  A United States national reference for fetal growth.

Authors:  G R Alexander; J H Himes; R B Kaufman; J Mor; M Kogan
Journal:  Obstet Gynecol       Date:  1996-02       Impact factor: 7.661

6.  Influence of socioeconomic factors on pregnancy outcome in women with structural heart disease.

Authors:  Iris M van Hagen; Sara Baart; Rebekah Fong Soe Khioe; Karen Sliwa-Hahnle; Nasser Taha; Malgorzata Lelonek; Luigi Tavazzi; Aldo Pietro Maggioni; Mark R Johnson; Nikolaos Maniadakis; Richard Fordham; Roger Hall; Jolien W Roos-Hesselink
Journal:  Heart       Date:  2017-11-01       Impact factor: 5.994

Review 7.  Maternal cardiac function, uteroplacental Doppler flow parameters and pregnancy outcome: a systematic review.

Authors:  M A M Kampman; C M Bilardo; B J M Mulder; J G Aarnoudse; C Ris-Stalpers; D J van Veldhuisen; P G Pieper
Journal:  Ultrasound Obstet Gynecol       Date:  2015-06-02       Impact factor: 7.299

Review 8.  Outcome of pregnancy in women with congenital heart disease: a literature review.

Authors:  Willem Drenthen; Petronella G Pieper; Jolien W Roos-Hesselink; Willem A van Lottum; Adriaan A Voors; Barbara J M Mulder; Arie P J van Dijk; Hubert W Vliegen; Sing C Yap; Philip Moons; Tjark Ebels; Dirk J van Veldhuisen
Journal:  J Am Coll Cardiol       Date:  2007-06-04       Impact factor: 24.094

9.  Heart failure in pregnant women with cardiac disease: data from the ROPAC.

Authors:  Titia P E Ruys; Jolien W Roos-Hesselink; Roger Hall; Maria T Subirana-Domènech; Jennifer Grando-Ting; Mette Estensen; Roberto Crepaz; Vlasta Fesslova; Michelle Gurvitz; Julie De Backer; Mark R Johnson; Petronella G Pieper
Journal:  Heart       Date:  2013-11-29       Impact factor: 5.994

10.  Educational disparities in perinatal health in Denmark in the first decade of the 21st century: a register-based cohort study.

Authors:  Josephine Funck Bilsteen; Josefine Bernhard Andresen; Laust Hvas Mortensen; Anne Vinkel Hansen; Anne-Marie Nybo Andersen
Journal:  BMJ Open       Date:  2018-11-08       Impact factor: 2.692

View more
  4 in total

1.  Patent Ductus Arteriosus in Pregnancy: Cardio-Obstetrics Management in a Late Presentation.

Authors:  Zhihang Zhang; Aaron Wengrofsky; Diana S Wolfe; Nicole Sutton; Manoj Gupta; Daphne T Hsu; Cynthia C Taub
Journal:  CASE (Phila)       Date:  2021-01-06

2.  Length of hospital stay after delivery among Danish women with congenital heart disease: a register-based cohort study.

Authors:  Anne Marie Kirkegaard; Maria Breckling; Dorte Guldbrand Nielsen; Janne S Tolstrup; Søren Paaske Johnsen; Annette Kjær Ersbøll; Stine Kloster
Journal:  BMC Pregnancy Childbirth       Date:  2021-12-07       Impact factor: 3.007

3.  Long-Term Cardiovascular Health After Pregnancy in Danish Women With Congenital Heart Disease. A Register-Based Cohort Study Between 1993 and 2016.

Authors:  Stine Kloster; Janne S Tolstrup; Dorte Guldbrand Nielsen; Lars Søndergaard; Søren Paaske Johnsen; Annette Kjær Ersbøll
Journal:  J Am Heart Assoc       Date:  2022-02-22       Impact factor: 6.106

4.  Maternal Risk Factors Triggering Congenital Heart Defects in Down Syndrome: A Case-Control Study.

Authors:  Ambreen Asim; Sarita Agarwal; Deepika Delsa Dean
Journal:  Pediatr Rep       Date:  2022-02-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.